Kate S Carroll Selected Research

Sulfenic Acids

1/2017	Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles.
9/2012	Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5.
9/2009	Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kate S Carroll Research Topics

Disease

7	Infections 01/2022 - 11/2008
6	Neoplasms (Cancer) 11/2018 - 09/2009
5	Tuberculosis (Tuberculoses) 06/2021 - 09/2009
2	Latent Tuberculosis 01/2015 - 11/2008
2	Latent Infection 01/2011 - 09/2009
1	Scrapie 01/2022
1	COVID-19 01/2022
1	Vascular Remodeling 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Thrombosis (Thrombus) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Fibrosis (Cirrhosis) 12/2018
1	Cysts 12/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Melanoma (Melanoma, Malignant) 09/2013
1	Atrial Fibrillation 09/2012
1	Pulmonary Hypertension 09/2012
1	Breast Neoplasms (Breast Cancer) 09/2009
1	Carcinogenesis 09/2009

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2009
5	Oxidoreductases (Dehydrogenase)IBA 06/2021 - 01/2011
4	Cysteine (L-Cysteine)FDA Link 01/2020 - 09/2009
4	Adenosine Phosphosulfate (Adenylyl Sulfate)IBA 01/2015 - 01/2011
3	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 09/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2017
3	Sulfenic AcidsIBA 01/2017 - 09/2009
3	Sulfates (Sulfates, Inorganic)IBA 09/2013 - 11/2008
3	adenylylsulfate reductaseIBA 09/2013 - 11/2008
2	(2R,3R,4R,5S)- 6- (((2S,3R,4R,5R)- 2,3,4,5,6- pentahydroxyhexyl)- (2- (4- (sulfanylmethyl)phenoxy)ethyl)amino)hexane- 1,2,3,4,5- pentolIBA 01/2022 - 12/2018
2	EnzymesIBA 01/2015 - 09/2009
2	SulfurIBA 01/2015 - 09/2013
2	mycothiolIBA 01/2014 - 08/2011
2	Melanocyte-Stimulating Hormones (MSH)IBA 01/2014 - 08/2011
2	Pharmaceutical PreparationsIBA 09/2013 - 11/2008
2	Iron-Sulfur ProteinsIBA 01/2011 - 09/2009
2	Antitubercular AgentsIBA 01/2011 - 09/2009
1	Complement System Proteins (Complement)IBA 01/2022
1	P-2165IBA 01/2022
1	AmmoniaIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Reducing AgentsIBA 01/2022
1	IminesIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Angiotensin IIIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	src-Family KinasesIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2018
1	Surface-Active Agents (Surfactants)IBA 12/2018
1	indium-bleomycinIBA 12/2018
1	MucinsIBA 12/2018
1	Expectorants (Mucolytics)IBA 12/2018
1	Protein CIBA 12/2018
1	cysteine sulfinic acidIBA 11/2018
1	PeroxiredoxinsIBA 11/2018
1	ProteomeIBA 01/2017
1	IronIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	PolymersIBA 09/2013
1	Horseradish PeroxidaseIBA 09/2012
1	StreptavidinIBA 09/2012
1	AntibodiesIBA 09/2009
1	Indicators and Reagents (Reagents)IBA 09/2009

Therapy/Procedure

1	Aftercare (After-Treatment) 09/2013
1	Therapeutics 09/2009
1	Drug Therapy (Chemotherapy) 11/2008